Hillhurst Biopharmaceuticals, Inc.
0 followers
‌
Hillhurst’s proprietary GLASS platform enables novel uses of therapeutic gases that, up until now, have been limited by inhaled delivery. We’ve developed a unique pipeline of novel liquid therapeutic candidates intended to treat patients with sickle cell disease, Parkinson’s disease, and acute pai... Read more
Industries
+2
Headquarters
Employees
Links
Org chart
Andrew Gomperts
President and CEO
Andrew Gomperts
Collapse
Onne Ganel
Business Development Lead
Jeffrey Friedman
Board Member
Alonso Guzman
Consultant: Regulatory Affairs And Operations, US Submission Management
